Anaphylaxis and monoamine oxidase inhibitors - The use of adrenaline

Journal of Accident and Emergency Medicine

Volumn 17, Issue 2, 2000, Pages 143-144

  Fenwick, M J ^a   Muwanga, C L ^a  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

Adrenaline; Anaphylaxis; Monoamine inhibitors

Indexed keywords

ADRENALIN; CHLORPHENIRAMINE; FLUCLOXACILLIN; HYDROCORTISONE; MONOAMINE OXIDASE INHIBITOR; OXYGEN; PHENELZINE; RANITIDINE;

AGED; AGITATION; ANAPHYLAXIS; ARTICLE; CASE REPORT; COLLAPSE; DEPRESSION; EMERGENCY TREATMENT; FEMALE; FLUSHING; GLOSSITIS; HUMAN; STRIDOR; TACHYCARDIA; WOUND INFECTION;

AGED; ANAPHYLAXIS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; EPINEPHRINE; FEMALE; FLOXACILLIN; HUMANS; MONOAMINE OXIDASE INHIBITORS; PHENELZINE; SYMPATHOMIMETICS;

EID: 0034015722     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Brown AFT. Therapeutic controversies in the management of acute anaphylaxis. J Accid Emerg Med 1998;15:89-95.
2. Fisher M. Treatment of acute anaphylaxis. BMJ 1995;311: 731-3.
3. Hardman JG, Limbird LE, eds. Goodman and Gillman's the pharmacological bash of therapeutics. 9th Ed. New York: McGraw-Hill, 1996: 442-6.
4. Graham-Smith DG, Aronson JK. Oxford textbook of clinical pharmacology and drug therapy. 2nd Ed. Oxford: Oxford University Press, 1992:639.
5. Livingston MG, Livingston HM. Monoamine oxidase inhibitors-an update on drug interactions. Drug Saf 1996;14:219-27.
6. Dawson JK, Earnshaw SM, Graham CS. Dangerous monoamine oxidase inhibitor interactions are still occurring in the 1990s. J Accid Emerg Med 1995;12:49-51.
7. Blackwell B. Monoamine oxidase inhibitor interactions with other drugs. J Clin Psychopharmacol 1991;11:55-9.
8. Elis J, Laurence DR, Mattie H, et al. Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure. BMJ 1967;ii:75-8.
9. Boakes AJ, Laurence DR, Teoh PC, et al. Interactions between sympathetic amines and antidepressant agents in man. BMJ 1973;i:311-5.
10. Cuthbert MF, Vere DW. Potentiation of the cardiovascular effects of some catecholamines by a monoamine oxidase inhibitor. Br J Pharmacol 1971;43:471-2.
11. Horwitz D, Goldberg LI, Sjoerdsma A. Increased blood pressure responses to dopamine and norepinephrine produced by a monoamine oxidase inhibitor. J Lab Clin Med 1960;56:747.
12. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British national formulary. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain, 1998;34:568.
13. Stockley IH. Drug interactions. 4th Ed. London: Pharmaceutical Press, 1996:668-9.